REQUEST A DEMO
Total
USD $0.00
Search more companies

Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) (Brazil)

Main Activities: All Other Miscellaneous Ambulatory Health Care Services
Full name: Imed - Instituto de Medicina, Estudos e Desenvolvimento Profile Updated: August 18, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2024 Available in: English & Portuguese Download a sample report

Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) is based in Brazil. The head office is in Uruacu. It operates in the All Other Miscellaneous Ambulatory Health Care Services industry. The company was established on December 13, 2021. From the latest financial highlights, Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) reported a net sales revenue increase of 14.57% in 2024. Over the same period, its total assets decreased by 62.97%.

Headquarters
Rua Anapolis S/N, Quadra28 Lote 09-A Sala 03, Centro
Uruacu; Goias; Postal Code: 76400000

Contact Details: Purchase the Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) report to view the information.

Website: http://imed.org.br

Basic Information
Total Employees:
Purchase the Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) report to view the information.
Financial Auditors:
Purchase the Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) report to view the information.
Incorporation Date:
December 13, 2021
Key Executives
Purchase this report to view the information.
Director
Company Performance
Financial values in the chart are available after Imed - Instituto de Medicina, Estudos e Desenvolvimento (Uruacu) report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency BRL. Absolute financial data is included in the purchased report.
Net sales revenue
14.57%
Total operating revenue
-16.85%
Operating profit (EBIT)
96.73%
EBITDA
96.73%
Total assets
-62.97%
Operating Profit Margin (ROS)
10.39%
Quick Ratio
-0.6%
Cash Ratio
-0.48%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?